Učitavanje...
Canagliflozin extends life span in genetically heterogeneous male but not female mice
Canagliflozin (Cana) is an FDA-approved diabetes drug that protects against cardiovascular and kidney diseases. It also inhibits the sodium glucose transporter 2 by blocking renal reuptake and intestinal absorption of glucose. In the context of the mouse Interventions Testing Program, genetically he...
Spremljeno u:
| Izdano u: | JCI Insight |
|---|---|
| Glavni autori: | , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society for Clinical Investigation
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7710304/ https://ncbi.nlm.nih.gov/pubmed/32990681 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.140019 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|